Recent News

576 News Items found
In an extraordinary demonstration of excellence, positive results from two separate studies of new therapies for the treatment of advanced melanoma were presented at the plenary session of the 2011 annual meeting of the American Society of Clinical Oncology by Paul Chapman, MD, and Jedd Wolchok MD, PhD, members of Memorial Sloan Kettering Cancer Center's Melanoma and Sarcoma service, and lead authors on the studies along with collaborators from more than a one hundred cancer centers worldwide.
Pictured: Craig Thompson
More than 500 high school students and their teachers filled the Rockefeller Research Laboratories to learn about recent discoveries.
An interdisciplinary team from Memorial Sloan Kettering Cancer Center has shown how antibiotics can disrupt the normal, healthy balance of microorganisms in the gastrointestinal tract.
Sloan Kettering Institute Director Thomas J. Kelly
Thomas Kelly Honored
Sloan Kettering Institute Director Thomas J. Kelly is the co-recipient of the 2010 Louisa Gross Horwitz Prize from Columbia University.
Bottles filled with liquid
A decade ago, the Sloan Kettering Institute embarked on an effort to broaden and streamline its research activities.
Alexander Rudensky
A team of researchers led by Memorial Sloan Kettering immunologist Alexander Rudensky has gained new understanding about regulatory T cells -- a subtype of immune cells that suppresses the immune system's reactivity.
Three Memorial Sloan Kettering Cancer Center investigators -- including the Center's new President, Craig B. Thompson -- have been featured with singer-songwriter Debbie Harry to lead the Geoffrey Beene Gives Back® 2010 Rock Stars of Science™ campaign in GQ magazine's December "Men of the Year" issue.
Hedvig Hricak (left) and David Scheinberg are members of the new Nanotechnology Center's executive committee, which Dr. Scheinberg chairs.
To take advantage of the growing field of nanotechnology, Memorial Sloan Kettering has established a Nanotechnology Center.
Zvi Fuks
Zvi Fuks has been elected a member of the Institute of Medicine, one of the highest honors in the fields of health and medicine.
Kenneth Offit
Media Advisory
An international study led by researchers at Memorial Sloan Kettering Cancer Center has identified genetic variants in women with BRCA2 mutations that may increase or decrease their risk of developing breast cancer.